Kinetoplastid 20S proteasome

The kinetoplastid 20S proteasome is a large, multi-subunit enzyme complex that serves as the primary machinery for non-lysosomal protein degradation in parasites such as Leishmania and Trypanosoma species [1]. It is composed of four stacked heptameric rings (two alpha and two beta rings) that form a barrel-like structure where proteolysis occurs [4]. This complex is essential for maintaining cellular proteostasis by degrading misfolded or regulatory proteins, which is critical for the parasite's cell cycle progression and survival within the host [2]. While the proteasome is a conserved feature in all eukaryotes, the kinetoplastid version possesses distinct structural pockets, particularly in the beta-4 and beta-5 subunits, that differ significantly from the human 20S proteasome [1, 3]. These differences have been exploited to develop highly selective inhibitors, such as LXE408 and GNF6702, which provide potent anti-parasitic activity with minimal impact on host cells [2, 5]. Targeting this complex leads to the rapid accumulation of polyubiquitinated proteins, resulting in proteotoxic stress and parasite death [1]. Consequently, the kinetoplastid 20S proteasome is a validated therapeutic target for neglected tropical diseases, including visceral leishmaniasis, Chagas disease, and Human African Trypanosomiasis [2, 3].

Other names

Trypanosomatid 20S proteasomeLeishmania 20S proteasomeTrypanosoma 20S proteasomeKinetoplastid multicatalytic endopeptidase complex

Selective inhibition of the catalytic beta subunits of the 20S proteasome, leading to the accumulation of polyubiquitinated proteins and subsequent parasite cell death [1, 2].